<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<base href="AFI%201/27/25%20ACS">
<title>A1825 ACS</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-link:"Comment Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:2.75pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:58.0pt;
	margin-bottom:.0001pt;
	text-indent:-30.05pt;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.SubType, li.SubType, div.SubType
	{mso-style-name:SubType;
	margin-top:0in;
	margin-right:-.75in;
	margin-bottom:0in;
	margin-left:-1.0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:18.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StateStyle, li.StateStyle, div.StateStyle
	{mso-style-name:StateStyle;
	margin-top:0in;
	margin-right:-.75in;
	margin-bottom:0in;
	margin-left:-1.0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:28.0pt;
	font-family:"Arial",sans-serif;
	letter-spacing:.2pt;
	font-weight:bold;}
p.SponsoredBy, li.SponsoredBy, div.SponsoredBy
	{mso-style-name:SponsoredBy;
	margin-top:0in;
	margin-right:-.75in;
	margin-bottom:0in;
	margin-left:-1.0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	letter-spacing:.2pt;
	font-weight:bold;}
p.IndentHang, li.IndentHang, div.IndentHang
	{mso-style-name:IndentHang;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.25in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuComLine, li.bpuComLine, div.bpuComLine
	{mso-style-name:bpuComLine;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.RightBrackt
	{mso-style-name:RightBrackt;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.Style10ptRight-025, li.Style10ptRight-025, div.Style10ptRight-025
	{mso-style-name:"Style 10 pt Right\:  -0\.25\0022";
	mso-style-link:"Style 10 pt Right\:  -0\.25\0022 Char";
	margin-top:0in;
	margin-right:-.25in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.Style10ptRight-025Char
	{mso-style-name:"Style 10 pt Right\:  -0\.25\0022 Char";
	mso-style-link:"Style 10 pt Right\:  -0\.25\0022";
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.BillFor, li.BillFor, div.BillFor
	{mso-style-name:BillFor;
	margin-top:0in;
	margin-right:-.75in;
	margin-bottom:0in;
	margin-left:-1.0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:18.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.BillPropBy, li.BillPropBy, div.BillPropBy
	{mso-style-name:BillPropBy;
	margin-top:0in;
	margin-right:-.75in;
	margin-bottom:0in;
	margin-left:-1.0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-link:"Comment Text";
	letter-spacing:.2pt;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	letter-spacing:.2pt;
	font-weight:bold;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuComLine><a name=bpuFrontPg></a>ASSEMBLY COMMITTEE SUBSTITUTE FOR</p>

<p class=bpuBill>ASSEMBLY, No. 1825 </p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  <span style='line-height:120%;letter-spacing:0pt'>ADOPTED
JANUARY 27, 2025</span></p>

<p class=bpuWpGraphic>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuWpGraphic>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Assemblyman  ANTHONY S. VERRELLI</p>

<p class=bpuSponsor>District 15 (Hunterdon and Mercer)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>Co-Sponsored by:</p>

<p class=bpuSponsor>Assemblywomen Murphy, Swain, Assemblyman Tully,
Assemblywoman Speight, Assemblymen Danielsen, Karabinchak, Assemblywomen
Quijano, Lopez, N.Munoz, Tucker, Reynolds-Jackson, Dunn, Assemblymen Stanley,
Sauickie, Clifton, Assemblywomen Haider, Swift, Assemblyman DeAngelo,
Assemblywoman Carter, Assemblymen Bergen, Guardian, Azzariti Jr., Assemblywoman
Matsikoudis, Assemblymen Sampson and Rodriguez</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Establishes certain guidelines for health insurance
carriers concerning step therapy protocols. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     Substitute as adopted by the Assembly Financial Institutions
and Insurance Committee.</p>

<p class=bpuNormText>   </p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><b><span style='font-variant:
small-caps'>An Act</span></b> concerning step therapy protocols and
supplementing Title 26 of the Revised Statutes.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><b>     <span style='font-variant:
small-caps'>Be It Enacted</span></b><span style='font-size:10.0pt;line-height:
150%'> </span><i>by the Senate and General Assembly of the State of New Jersey:</i></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     1.    The
Legislature finds and declares that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     a.     To
address the increasingly high cost of prescription drug utilization and to
address patient safety, health</span><sup> </sup><span style='color:black'>insurance</span><b><sup>
</sup></b><span style='color:black'>carriers and other plan sponsors use step
therapy protocols that require patients to try one or more prescription drugs
before coverage is provided for a drug selected by the patients health care
provider.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     b.    Step
therapy protocols, if based on well-developed scientific standards and
administered in a flexible manner that takes into account the individual needs
of patients, can play an important role in controlling health care costs.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     c.     Requiring
a patient to follow a step therapy protocol may have adverse and even dangerous
consequences for the patient, who may either not realize a benefit from taking a
prescription drug or may suffer harm from taking an inappropriate drug.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     d.    It
is imperative that step therapy protocols in the State preserve the heath care
providers right to make medically necessary treatment decisions in the best
interest of the patient.</span></p>

<p class=MsoNormal style='line-height:150%'>     e.     <span style='color:
black'>The Legislature declares, therefore, that it is a matter of public
interest that health insurance carriers be required to base step therapy
protocols on appropriate clinical practice guidelines or published
peer-reviewed data developed by independent experts with knowledge of the
condition or conditions under consideration; that patients be exempt from step
therapy protocols when those protocols are inappropriate or otherwise not in
the best interest of the patients; and that patients have access to a fair,
transparent and independent process for requesting an exception to a step
therapy protocol when the patients physician deems appropriate.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     2.    As
used in this act:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     &quot;Carrier&quot;
means an insurance company, health service corporation, hospital service
corporation, medical service corporation, or health maintenance organization
authorized to issue health benefits plans in this State.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     Commissioner
means the Commissioner of Banking and Insurance.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     &quot;Covered
person&quot; means a person on whose behalf a carrier offering the plan is
obligated to pay benefits or provide services pursuant to the health benefits
plan.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     &quot;Health
benefits plan&quot; means a benefits plan which pays or provides hospital and
medical expense benefits for covered services, and is delivered or issued for
delivery in this State by or through a carrier.&nbsp; </span>For the purpose of
this act, &quot;health benefits plan&quot; shall include the School Employees
Health Benefits Plan, the State Employees Health Benefits Plan, and Medicaid,
and shall not include the following plans, policies, or contracts: commercial
market plans including individual, small and large group plans, Medicare,
Medicare Advantage, Medicare supplement, accident only, credit, disability,
long-term care, TRICARE supplement coverage, coverage arising out of a workers'
compensation or similar law, automobile medical payment insurance, personal
injury protection insurance issued pursuant to P.L. 1972, c.70 (C.39:6A-1 et
seq.), and hospital confinement indemnity coverage.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Health care
provider&quot; means an individual or entity which, acting within the scope of
its licensure or certification, provides<span style='color:black'> a covered
service defined by the health benefits plan.&nbsp; Health care provider
includes, but is not limited to, a physician and other health care professionals
licensed pursuant to Title 45 of the Revised Statutes, and a hospital and other
health care facilities </span>licensed pursuant to Title 26 of the Revised
Statutes.</p>

<p class=MsoNormal style='line-height:150%'>     Medical necessity&quot; or
&quot;medically necessary&quot; means the same as those terms are defined in section
4 of P.L.2023, c.296 (C.17B:30-55.3).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy exception means
the<span style='color:black'> overriding of a step therapy protocol in favor of
immediate coverage of the health care providers selected prescription drug.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     Step
therapy protocol means a protocol, policy, or program that establishes the
specific sequence in which prescription drugs for a specified medical
condition, and medically appropriate for a particular patient, are required to
be administered in order to be covered by a health benefits plan.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     Utilization
review organization means an entity that conducts utilization review, other
than a carrier performing utilization review for its own health benefit plans.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'> </span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     3.    a.
Clinical review criteria used to establish a step therapy protocol shall be
based on </span>clinical <span style='color:black'>practice guidelines
developed by the carrier that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (1)   
recommend that the prescription drugs be taken in the specific sequence
required by the step therapy protocol;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (2)   are
developed and endorsed by a multidisciplinary panel of experts that: </span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (a)   relies
on objective data; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (b)   manages
conflicts of interest among the members by requiring members to disclose any
potential conflict of interests with entities, including carriers and
pharmaceutical manufacturers and recuse themselves from voting if they have a
conflict of interest;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (3)   are
based on high quality studies, research, and medical practice;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (4)   are
created by an explicit and transparent process that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (a)   minimizes
biases and conflicts of interest;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (b)   explains
the relationship between treatment options and outcomes;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (c)   rates
the quality of the evidence supporting recommendations; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (d)   considers
relevant patient subgroups and preferences; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (5)   
are </span>reviewed annually or quarterly if there is a new indication or new clinical
information available and <span style='color:black'>updated when such review
reveals new evidence necessitating modification.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     b.    In
the absence of clinical guidelines that meet the requirements in subsection a.
of this section, peer-reviewed publications may be substituted.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     c.     When
establishing a step therapy protocol, a utilization review agent shall also
consider the needs of atypical patient populations and diagnoses when
establishing clinical review criteria.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     d.    A
carrier shall:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (1)   upon
written request, provide written clinical review criteria relating to a
particular condition or disease, including clinical review criteria relating to
a step therapy protocol exception determination; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (2)   make
available the clinical review criteria and other clinical information of a
particular drug on the provider portal of the Internet website of the carrier
and upon written request to non-profit health care organizations, subject to
redaction as may be necessary.  When releasing to non-profit health care
organizations, a carrier may redact information as may be permitted by the
Department of the Treasury for the State Health Benefits Program or the
Department of Human Services for the New Jersey FamilyCare Program.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     e.     This
section shall not be construed to require carriers or the State to establish a
new entity to develop clinical review criteria used for step therapy protocols.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     4.    Notwithstanding
the provisions of any law, rule, or regulation to the contrary:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     a.     When
coverage of a prescription drug for the treatment of any medical condition is
restricted for use by a carrier or utilization review organization pursuant to
a step therapy protocol, the carrier or utilization review organization shall
provide the covered person and prescribing practitioner a clear, readily accessible,
and convenient process to request a step therapy exception. A carrier or
utilization review organization may use its existing medical exceptions process
to satisfy this requirement. An explanation of the process shall be made
available on the carrier or utilization review organizations website.&nbsp; A
carrier or utilization review organization shall disclose all rules and
criteria related to the step therapy protocol upon request to all prescribing
practitioners, including the specific information and documentation required to
be submitted by a prescribing practitioner or patient for an exception request
to be complete.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     b.    A
step therapy exception shall be granted if the prescribing health care provider
determines that</span><span style='letter-spacing:.1pt'>:</span></p>

<p class=MsoNormalCxSpMiddle style='line-height:150%'>     (1)   the required
prescription drug is contraindicated or is likely to cause an adverse reaction
or physical or mental harm to the patient;</p>

<p class=MsoNormalCxSpMiddle style='line-height:150%'><span style='color:black'>     (2)   the
required prescription drug is expected to be ineffective or less effective than
an alternative based on the known clinical characteristics of the patient and
the known characteristics of the prescription drug regimen; or</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (3)   all
formulary drugs used to treat each disease state have been ineffective or less
effective than an alternative in the treatment of the covered person's disease
or condition, or all such drugs have caused or are reasonably expected to cause
adverse or harmful reactions in the covered person.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     If
requested by a carrier, the prescribing health care provider shall provide
documentation to support the determinations made by the provider pursuant to
paragraphs (1) through (3) of this subsection.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     c.     When
a step therapy exception is granted, the carrier or utilization review
organization shall authorize coverage for the prescription drug prescribed by
the patients treating health care provider at least 180 days or the duration
of therapy if less than 180 days</span><span style='letter-spacing:.15pt'>,
provided that the prescription drug is covered by the patients health care
plan.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     d.    Any
step therapy exception shall be eligible for appeal by a covered person.&nbsp;
The carrier or utilization review organization shall grant or deny a step
therapy exception request or an appeal of a step therapy exception request
within a time frame appropriate to the medical exigencies of the case but no
later than&nbsp;24 hours for urgent requests and 72 hours for non-urgent
requests after obtaining all necessary information to make the approval or
adverse determination.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     e.     Any
step therapy exception pursuant to this section shall be eligible for appeal by
a covered person.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     f.     This
section shall not be construed to prevent:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (1)   a
carrier or utilization review organization from requiring a patient to try an
AB-rated generic equivalent or interchangeable biological product prior to
providing coverage for the equivalent branded prescription drug;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (2)   a
carrier or utilization review organization from requiring a pharmacist to
effect substitutions of prescription drugs consistent with the laws of this
State; or</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (3)   a
health care provider from prescribing a prescription drug that is determined to
be medically appropriate.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     5.    A
carrier or utilization review organization shall make statistics available
regarding step therapy exception request approvals and denials on its Internet
website in a readily accessible format, as determined by the Commissioner of
Human Services.  The Commissioner of Human Services shall determine by
regulation the statistics and format of the statistics that are made available.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     6.    The
Commissioner of Banking and Insurance and the Commissioner of Human Services shall
adopt, pursuant to the Administrative Procedure Act P.L.1968, c.410
(C.52:14B-1 et seq.), rules and regulations to effectuate the purposes of this act.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     7.    The
Commissioner of Human Services shall apply for such State plan amendments or
waivers as may be necessary to implement the provisions of this act and secure
federal financial participation for State Medicaid expenditures under the
federal Medicaid program. Prior to the implementation of this act, the
Commissioner of Human Services shall provide a separate rate certification for
this program and benefit change within the acute care and managed long-term
services and supports programs in compliance with federal standards including
but not limited to 42 C.F.R. 438.4.  Implementation of this program and benefit
change during the course of a State Fiscal Year shall require a mid-year
managed care rate adjustment for the acute care and managed long term services
and supports program.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     8.    This
act shall take effect on the 60th day after enactment and apply to all
contracts and policies delivered, issued, executed, or renewed on or after
January 1,</span><sup> </sup><span style='color:black'>2026.</span></p>

</div>

</body>

</html>
